Invention Grant
- Patent Title: Methods for treating HCV
- Patent Title (中): 治疗HCV的方法
-
Application No.: US13656012Application Date: 2012-10-19
-
Publication No.: US08809265B2Publication Date: 2014-08-19
- Inventor: Barry M. Bernstein , Rajeev M. Menon , Amit Khatri , Sven Mensing , Sandeep Dutta , Daniel E. Cohen , Thomas J. Podsadecki , Scott C. Brun , Walid M. Awni , Emily O. Dumas , Cheri E. Klein
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Xu Zhang
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/00 ; A61P1/16 ; A01N43/04 ; A61K31/70 ; A61K31/4709 ; A61K31/7072 ; A61K31/4725 ; A61K31/4025 ; A61K31/501 ; A61K45/06 ; A61K31/5377 ; A61K31/513 ; A61K31/4178 ; A61K31/473 ; A61K31/4196

Abstract:
The present invention features interferon- and ribavirin-free therapies for the treatment of HCV. Preferably, the treatment is over a shorter duration of treatment, such as no more than 12 weeks. In one aspect, the therapies comprise administering at least two direct acting antiviral agents without interferon and ribavirin to a subject with HCV infection. For example, the therapies comprise administering to a subject an effective amounts of therapeutic agent 1, therapeutic agent 2 (or therapeutic agent 3), and an inhibitor of cytochrome P450 (e.g., ritonavir).
Public/Granted literature
- US08680048B2 Methods for treating HCV Public/Granted day:2014-03-25
Information query
IPC分类: